Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents
2022; Lippincott Williams & Wilkins; Volume: 57; Issue: 10 Linguagem: Inglês
10.1097/rli.0000000000000883
ISSN1536-0210
AutoresRichard C. Semelka, Miguel Ramalho,
Tópico(s)Radioactive element chemistry and processing
ResumoFrom the ∗Richard Semelka, MD, Consulting PLLC, Chapel Hill, NC †Department of Radiology, Hospital da Luz, Lisbon ‡Department of Radiology, Hospital Garcia de Orta, EPE, Almada, Portugal. Received for publication March 17, 2022; and accepted for publication, after revision, March 20, 2022. Conflicts of interest and sources of funding: none declared. Correspondence to: Richard C. Semelka, MD, 3901 Jones Ferry Rd, Chapel Hill, NC, 27516. E-mail: [email protected].
Referência(s)